Ventriculo-arterial coupling: from physiological concept to clinical application in peri-operative care and ICUs : European Journal of Anaesthesiology and Intensive Care

Secondary Logo

Journal Logo

REVIEW ARTICLE

Ventriculo-arterial coupling: from physiological concept to clinical application in peri-operative care and ICUs

Guinot, Pierre-Grégoire; Andrei, Stefan; Longrois, Dan

Author Information
European Journal of Anaesthesiology and Intensive Care 1(2):p e004, April 2022. | DOI: 10.1097/EA9.0000000000000004
  • Open

Abstract

KEY POINTS

  • Ventriculo-arterial coupling is a concept that describes the interaction of the left ventricle and the vascular system in terms of volume/pressure relationship.
  • Ventriculo-arterial coupling is estimated as the ratio of two elastances: arterial elastance and ventricular elastance.
  • The main categories of cardio-circulatory failures observed in intensive care patients commonly exhibit typical patterns of alteration in ventriculo-arterial coupling.
  • Restoring ventriculo-arterial coupling with haemodynamic treatments improves tissue perfusion and outcomes in subgroups of intensive care patients; however, further studies are necessary.

Introduction

Even though ventriculo-arterial coupling has been studied and used in clinical practice in cardiology for more than 30 years, its relevance in anaesthesia and ICU remains poorly known and used. Anaesthesiologists/intensivists have to deal with several haemodynamic alterations and circulatory abnormalities requiring integrated knowledge of physiology/pathophysiology of the cardiovascular system. In the classic haemodynamic approach, the heart and the arterial system are described as distinct structural and functional entities. Variables, such as cardiac output (CO) and mean arterial pressure, are analysed separately in many situations, and their interactions are rarely numerically described. However, the heart and the arterial vascular tree, including the aorta, are interdependent systems that are complementary and sometimes competitive. All compartments contribute to overall cardiovascular system homeostasis and performance, although no compartment function can be modified without altering the other. Ventriculo-arterial coupling is a physiological concept that describes the interaction of the left ventricle (LV) and the arterial system (principally the aorta). Noninvasive methods to assess ventriculo-arterial coupling are now available at the bedside.1 Complementary to the haemodynamic approach based on cardiac efficacy (i.e. maximisation of CO), ventriculo-arterial coupling assessment confers an insight into cardiac efficiency, which is the energy required to provide a defined output.

In the era of personalised medicine, opportunities for haemodynamic optimisation must be considered. In this respect, ventriculo-arterial coupling concepts and clinical estimators used in anaesthesia and in the ICU can be regarded as novel.

Definitions that build operational knowledge of ventriculo-arterial coupling

Determinants of ventriculo-arterial coupling

Functionally, the heart and the arteries adapt to each other during the cardiac cycle to generate CO and blood pressure.2 This statement is true for the right ventricle/pulmonary artery and LV/aorta coupling. In this article, the term ventriculo-arterial coupling is restricted to the LV/aorta.3 The LV pumps a blood volume during a cardiac cycle that is ejected into the arterial system (aorta). The arterial system represents a load opposed to the ejection of blood from the heart and modulates its performance and energetics. Ventriculo-arterial coupling refers to this interaction during the cardiac cycle of the LV with the arterial system. In other words, the systole–diastole succession concerns not only the cardiac pump but also the vascular system. The ventriculo-arterial coupling is based on an integrated pressure–volume relationship of the LV and arterial system.4–7 Ventriculo-arterial coupling is estimated as the ratio of two elastances: the arterial elastance (EA) and LV elastance (EV) (ventriculo-arterial coupling = EA/EV, Fig. 1).

F1
FIGURE 1:
Left ventricular pressure–volume curve. EDV, left ventricular end-diastolic volume (ml); ESPVR, end systolic pressure volume relationship; ESV, left ventricular end-systolic volume (ml); SV, stroke volume (ml).

The EV, specifically the end-systolic EV, is a characteristic of cardiac function, contractility and morphology and is independent of preload and afterload.8 The EV can be derived from the LV pressure-volume loop (PVL) for a given beat-to-beat preload and afterload. The PVL is based on the linear relationship between the end-systolic ventricular pressure and the end-systolic LV volume: the end-systolic pressure–volume relationship (ESPVR) (Fig. 1). The EV represents the necessary intracavitary pressure required to increase its volume by one unit (mmHg ml−1 = elastance).1 The EV is the slope of the line connecting V0 to the ESPVR. V0, which is the volume–axis intercept of the linearly projected ESVPR, to the ESPVR. V0 represents a theoretical left ventricular volume at zero intracavitary pressure. In humans, the normal value of EV is 2.3 ± 1 mmHg ml−1.9,10

The arterial load represents all extra-cardiac forces opposed to left ventricular ejection: the arterial afterload. The best parameter for describing these forces may be the aortic input impedance, but it is assessed in the frequency domain. To overcome this issue, we can describe the arterial load by the slope of the relationship between the stroke volume (SV) and end-systolic arterial pressure: the arterial effective elastance (EA). EA does not actually represent the elastance of a specific segment of the arterial tree but a cumulative parameter of the entire arterial system. EA represents arterial function, and it can be assimilated to the net arterial load characterised by the total peripheral resistance, characteristic impedance and systolic and diastolic time intervals.8,11EA=Rt[ts+τ×(1e-td/τ)]where ts and td are the systolic and diastolic periods, respectively. Rt is the total mean vascular resistance (peripheral resistance and characteristic impedance), and τ is the diastolic time constant.

Evidently, on the basis of the above formula, the restrictive use of systemic vascular resistance to estimate the behaviour of the arterial system is simplistic. EA can also be represented as the slope of the line connecting the left ventricular end-diastolic volume to ESPVR1 (Fig. 2). In humans, the normal value of EA is 2.2 ± 0.8 mmHg ml−1.9,12

F2
FIGURE 2:
Left ventricular pressure–volume loop.

In humans, the mean value of EA/EV ratio is 1 ± 0.36.9,12 Consequently, an uncoupled value indicates a ratio of elastances outside this range. Ventriculo-arterial uncoupling can be due to the results of alterations of EA, EV or both. Importantly, ventriculo-arterial coupling may be preserved despite considerably altered values of EA and EV, and therefore, a complete analysis of ventriculo-arterial coupling requires the analysis and interpretation of all components (i.e. EA, EV and EA/EV).

KEY POINTS

EV is the slope of the line connecting V0 to the ESVPR. It is a (nearly) load-independent left ventricular function parameter. Normal values for EV = 2.3 ± 1 mmHg ml−1.

EA is the slope of the line connecting the left ventricular end-diastolic volume to the ESPVR. It is a vascular function parameter that integrates the pulsatile and continuous components of the arterial load. Normal values for EA = 2.2 ± 0.8 mmHg ml−1.

Ventriculo-arterial coupling is the ratio EA/EV, and the normal values are 1 ± 0.36.

A complete evaluation of ventriculo-arterial coupling requires the analysis of all three parameters: EA, EV and EA/EV.

Relationship of ventriculo-arterial coupling with left ventricular energetics

The efficacy and efficiency of the cardiovascular system are the result of regulated interactions between the heart and the vascular system. Cardiovascular performance can not only be evaluated in terms of efficacy (blood pressure and blood flow) but also in terms of efficiency (i.e. energetic cost for the cardiovascular system to provide the same blood pressure and blood flow). Ventriculo-arterial coupling represents a clinical parameter of cardiovascular efficiency. Ventriculo-arterial coupling adequacy is one of the main determinants of myocardial energetics during the transfer of an SV from the heart to the arterial system in a beat-to-beat interplay between left ventricular contractility and arterial load.

From any given ventricular PVL, different energy measures can be obtained: stroke work and potential energy (Fig. 2).13 The total energy consumed during the cardiac cycle is the sum of stroke work and potential energy, which is designated on the PVL as the pressure–volume area (PVA).13 The PVA is linearly correlated to myocardial oxygen consumption.13 Stroke work is the effective left ventricular energy that may be transmitted to the arterial system. Potential energy signifies the dissipated energy during the left ventricular isovolumetric contraction. Left ventricular efficiency is the ratio between stroke work and PVA. Stroke work is calculated as ESPVR × SV. Potential energy is calculated as ESPVR × ((ESV − V0)/2) and assumes that V0 is negligible compared to ESV.13

Left ventricular efficiency is maximised during normal physiological situations with an EA/EV of 0.5. During stressful haemodynamic situations, stroke work is maximised, reaching a maximum EA/EV ratio of 1.1 The energetic balance of the cardiovascular function is optimal when EA/EV is 1, whereas at a ratio of 0.5, maximal cardiac efficiency is observed.14 An alteration in this ratio is both a marker of disease severity and an independent predictor of outcome in cardiovascular diseases.15–18 Ventriculo-arterial coupling is a parameter of cardiac work efficiency. Most literature performed in ICU and anaesthesia concerning haemodynamic alterations and their correction focuses on the efficacy of the cardiovascular system (its performance). Efficiency, which is the myocardial energy expenditure necessary for a given cardiac output and vascular performance, is rarely considered.

Key points

Left ventricular stroke work: Left ventricular energy delivered to the arterial system to maintain pressure

Potential energy: Left ventricular energy dissipated during isovolumetric relaxation

PVA: stroke work + potential energy, linearly correlated to myocardial O2 consumption

Left ventricular efficiency = stroke work/PVA

Measurement of the left ventricular-arterial coupling at bedside

The gold standard for measuring ventriculo-arterial coupling is the invasive measurement of ventricular volumes and pressures to assess PVL and to calculate EA and EV.14 This invasive method requires the use of a conductance catheter and the manipulation of the loading conditions to obtain EV from multiple heartbeats; however, this method is not feasible in clinical practice. Several noninvasive single-beat methods have been developed and validated against the multiple-beat gold standard method to overcome this problem.19,20 None of these methods are interchangeable,20 requiring the use of the same method to evaluate the effects of interventions on ventriculo-arterial coupling. EA and EV can be measured using noninvasive cardiac echography coupled with blood pressure measurements.

The simplest method is:

Ev=0.9×systolicarterialpressure/leftventricularend-systolicvolume20

The recommended method is the single-beat method, which was developed by Chen et al. (Fig. 3).1,21 Chen's method is based on measurements of diastolic arterial blood pressure, systolic arterial blood pressure, SV, left ventricular ejection fraction and the estimated normalised ventricular elastance (End).

Ev=(DAP[End(est)×SAP×0.9)]/End(est)×SV
F3
FIGURE 3:
Chen's single-beat method was used to calculate ventricular elastance.

DAP: diastolic blood pressure; SAP: systolic blood pressure; SV: stroke volume; End: estimated normalised ventricular elastance; tNd: the ratio of the pre-ejection period to the total systolic period.

End average is calculated by a polynomial formula based on pre-ejection and ejection times. This method has the vulnerability of maximising errors in tNd measures.1 Another limit is the premise that End is nearly constant and unaffected by different physiological conditions or cardiac diseases, which have not yet been fully validated.

EA calculation is based on the SV and end-systolic pressure measurements. End-systolic pressure can be estimated as 90% of the SAP, as the mean aortic pressure or as the aortic dicrotic notch pressure.22 Some haemodynamic devices (MOSTCARE™) already integrate the calculation of EA as the peripheral dicrotic notch pressure to SV ratio. Given that the accuracy of this measure may depend on the arterial site measurements and underlying disease, the estimation of end-systolic pressure based on MAP may offer a better surrogate over different haemodynamic conditions and when measured interchangeably in any peripheral arterial site.22

EA=0.9×SAP/SV=MAP/SV=MAP×HR/CO=HR×peripheralresistances

MAP: mean arterial pressure; SAP: systolic arterial pressure; SV: stroke volume; HR: heart rate; CO: cardiac output; × designates multiplication

Continuous monitoring of ventriculo-arterial coupling: A place for dynamic arterial elastance

Dynamic arterial elastance (Eadyn) is the ratio of respiratory variation of pulse pressure to respiratory variation of SV.23 Eadyn can be measured with several haemodynamic monitors (MOSTCARE, PICCO)™ or with cardiac echography. Given that its measure is based on the relationship between SV and pulse pressure, Eadyn may be an indicator of ventriculo-arterial coupling. An animal study that manipulated preload, afterload and inotropism demonstrated an association between Eadyn and ventriculo-arterial coupling.24 Subsequently, Eadyn has been demonstrated to be associated with oscillatory power fraction and energy efficiency ratio in septic shock. In this manner, Eadyn can be used as an indicator of cardiovascular efficiency. Such an association has not been demonstrated in humans during norepinephrine administration.25 Underlying disease and haemodynamic treatment may affect the relationship between SV, pulse pressure and ventriculo-arterial coupling.26–29 Several studies have demonstrated the ability of the Eadyn to predict successful norepinephrine weaning and thus decrease the time exposure to the vasopressor.25–29 This index has been integrated in haemodynamic algorithms to predict further intra-operative hypotension with good predictive value.30 In summary, Eadyn can be used to understand the interaction between cardiac function and arterial load and the effects of haemodynamic treatment on arterial load components and thus to determine which treatments can be used or withdrawn.27–29 Presumably, asserting that Eadyn is a clinically acceptable surrogate of ventriculo-arterial coupling under all pathophysiological conditions and for all patients admitted to intensive care or in the peri-operative period is currently inappropriate. Before the widespread use of the Eadyn, we must have more interventional studies regarding this parameter.

Ventriculo-arterial coupling in different contexts

In anaesthesia practice

There are limited data on the effects of commonly used anaesthetic drugs on ventriculo-arterial coupling. Pittarello et al.31 demonstrated that despite a decrease of EA and EV with remifentanil, ventriculo-arterial coupling remains unchanged. A study evaluating the effects of general anaesthesia with propofol/remifentanil infusion and positive pressure ventilation demonstrated a decrease in EV with the induction of anaesthesia and a trend for a decrease in EA; ventriculo-arterial coupling is globally unchanged.32 Given that anaesthetic drugs can alter vascular properties, they can alter the EA, with a reduced effect on EV.33

In acute care and intensive care practice

Intensive care practitioners have to manage different states of acute cardio-circulatory dysfunction/failure, implying alterations of EA, EV or both. Large-scale prevalence epidemiological data on ICU patients are not available; however, ventriculo-arterial uncoupling is likely in these clinical contexts and as suggested by various studies.16–18,34 The phenotypes of cardio-circulatory failure with proposed mechanisms of potential ventriculo-arterial uncoupling are presented in Table 1 and discussed briefly in the following section.

TABLE 1 - Ventriculo-arterial coupling and its determinants in common cardio-circulatory failure.
Cardiocirculatory failure Phenotype EV EA EA/Ev ratio
Vasoplegia ↓↓ ↓↓
Sepsis Hyperkinetic ↓↓ ↓↓
Normokinetic ∼/↓ ∼/↓ ∼/↑
Hypokinetic ↓↓ ∼/↑
Left heart failure Systolic heart failure ↓↓ ∼/↑
‘Diastolic’ heart failure (heart failure with preserved ejection fraction) ∼/↑
Cardiogenic shock ↓↓↓ ∼/↓↓ ↑↑
Right heart failure Pulmonary embolism ∼/↑
Pulmonary hypertension ∼/↑
Ischemic ↓↓
Tachycardia ∼/↑ ↑↑ ∼/↑
Severe arterial hypertension ∼/↓ ↑↑
Hypovolemia ↑↑
Trauma Haemorrhage ∼/↓ ↑↑
Systemic inflammatory response syndrome ↓↓
Anaphylaxis ↓↓
Compiled from ref.6–51

Heart rate values and ventriculo-arterial coupling

Given that EA is modulated by systolic and diastolic times, any changes in heart rate must be able to change its value. In healthy dogs, an increase in heart rate during exercise is associated with an increase in EV, which can match with EA in maintaining nearly optimal ventriculo-arterial coupling.35 This effect is known as the force–frequency relationship of the ventricle (the Bowditch effect), which is an intrinsic property of cardiac muscle. This effect is altered in heart failure.36 In such situations, ventriculo-arterial coupling is altered at rest, and any increase in heart rate values exacerbates ventriculo-arterial uncoupling because EA is not counterbalanced by an increase in EV.36

Hypovolaemia is a common acute care situation characterised by ventriculo-arterial uncoupling through high EA induced by sympathetic activation to maintain tissue perfusion.34 In this case, severe tachycardia may further increase EA and aggravates the ventriculo-arterial uncoupling.36

Vasoplegic syndrome

Vasoplegic syndrome is another type of cardio-circulatory instability of different inflammation-mediated causes that is frequently seen in ICU patients. This syndrome is usually observed in sepsis, polytrauma, anaphylaxis or after major cardiac and non-cardiac surgeries.37–40 Vasoplegic syndrome is characterised by several alterations of vascular homeostasis that lead to severe arterial hypotension with low systemic vascular resistance, altered arterial compliance41 and changed pulse wave velocity propagation. In general, cardiac output is maintained or increased, but it can be altered. From a physiological perspective, vasoplegic syndrome concerns only the vascular component, which is EA, with a high EA/EV ratio. The ventricular function (i.e. EV) is not altered. In clinical practice, ventricular function (i.e. EV) can be altered by the underlying process (e.g. sepsis-induced myocardial depression) and/or by myocardial dysfunction in relation to arterial hypotension or dyssynchrony.39,42,43

Sepsis

Sepsis is not a homogeneous entity in terms of haemodynamic phenotypes. Several clinical haemodynamic phenotypes have been described.44,45 The prevalence of ventriculo-arterial uncoupling in sepsis has not yet been evaluated in large cohorts of patients. From published studies, approximately 70% of patients with septic shock may have ventriculo-arterial uncoupling.40,42,46,47 Shock alteration plays a central role in vascular properties with severe vasoplegia.48 Nevertheless, the decrease in EA (hyperkinetic phenotype) is not the only pattern observed in sepsis. A hypokinetic phenotype, with a decrease in left ventricular function (EV), can also be observed. The normokinetic phenotype is associated with less EA and EV alterations. In resuscitated patients with sepsis, persistent tachycardia can be a supplementary factor of ventriculo-arterial uncoupling by decreasing diastolic filling (thus reducing cardiac output), which is associated with increased mortality.49 Moreover, fluid infusion and vasopressive and inotropic drugs can further alter vascular properties and cardiac function, thus modifying EA, EV and ventriculo-arterial uncoupling.41

Acute left-sided heart failure

Acute decompensated heart failure is characterised by a high EA/EV ratio, which is caused by high EA and low EV.50 Because of low EV, patients are highly sensitive to EA, particularly through high heart rate values.51 Tachycardia, in the context of heart failure, is associated with an increase in EA because of a decrease in diastolic time and vascular compliance.36,52 Moreover, as previously stated, the increase in EA cannot be counterbalanced by an increase in EV; the frequency potentiation of contractile function is decreased in the failing heart. Cardiogenic shock is the most severe form of circulatory failure. It is associated with a severe decrease in EV and an initial increase and then a decrease in EA.53–55 Ventriculo-arterial coupling utility is debated in the context of acute heart failure with a preserved ejection fraction. In this clinical situation, a concomitant increase in both EA (increased stiffness) and EV (cardiac hypertrophy and remodelling) occurs, making their ratio, but not their individual values, less meaningful.1 However, some studies have suggested a heterogeneity in this population, with the existence of a subgroup with high EV and less unchanged EV relation.51

Clinical relevance of ventriculo-arterial coupling evaluation and manipulation

Clinical outcomes

In chronic cardiovascular diseases, the main effective therapeutic interventions have been demonstrated to improve ventriculo-arterial coupling, thus affecting clinical outcomes (Table 2).1 Several studies in acute heart failure have demonstrated an improvement in ventriculo-arterial coupling by inotropes and/or inodilators.53–59 During refractory cardiac failure, some patients require extracorporeal membrane oxygenation (ECMO). Veno-arterial femoro-femoral ECMO implantation with resulting retrograde ECMO arterial flow, in the clinical context of already impaired ventriculo-arterial coupling, is associated with further alteration of ventriculo-arterial coupling because of an increase in EA (low SV and high retrograde blood pressure).60,61 In this context, the use of a microaxial nonpulsatile aortic assistance is associated with improved ventriculo-arterial coupling by decreasing EA and slightly increasing EV.62 Veno-arterial axillary EMCO implantation can avoid the deleterious effects of retrograde arterial flow.63

TABLE 2 - Main effects on determinants of ventriculo-arterial coupling of the therapeutics used in acute care
Effects

Treatment EA EV
Inotrope/inodilator ↑↑
Phenylephrine ↑↑ ∼↓
Norepinephrine ↑↑
Epinephrine ↑↑
Vasodilator
Volume expansion
Beta-blocker ∼↓
Loop diuretics and decongestion
VA-ECMO (retrograde arterial flow) ∼↓
Axial pump flow (LV unloading) ∼↑

For ICU patients, ventriculo-arterial uncoupling is not an incidental finding, as it is an independent predictor of morbidity and mortality in several settings (e.g. septic shock and cardiac ICU trauma).15,16,64 In a cohort of trauma patients admitted to the ICU, survivors show a better ventriculo-arterial coupling ratio than nonsurvivors, which is explained by reduced EA and increased Ev.65 Chang et al.66 further suggested that a haemodynamic optimisation approach based on improved ventriculo-arterial coupling is associated with improved tissue perfusion and less organ dysfunctions. Ventriculo-arterial coupling may be associated with VO2 changes in ICU patients.17 Interestingly, VO2 responders are characterised by improvement in ventriculo-arterial coupling, indifferently of the used haemodynamic intervention.17 Recently, a randomised pilot study demonstrated the feasibility of optimising ventriculo-arterial coupling in the early phase of patients with septic shock.18 Such an approach appears promising because it has been associated with improved lactate clearance and a trend to reduce mortality. Further randomised studies are needed to confirm these results.

Effects of haemodynamic therapeutics on ventriculo-arterial coupling

Several studies evaluating the effect of cardiovascular therapeutics (e.g. volume expansion, norepinephrine and inotropes) demonstrated an association between ventriculo-arterial coupling status and the clinical effect of each intervention. These therapeutic interventions, by improving ventriculo-arterial coupling, restore blood pressure and blood flow and possibly improve cardiac energetics (see above). Preload-dependent patients have a high baseline ventriculo-arterial coupling ratio in relation to high EA. Volume expansion improves ventriculo-arterial coupling by decreasing EA, and in some cases (patients with sepsis), by increasing EV.34 The ventriculo-arterial coupling may be connected to the role of systemic EA changes in maintaining SV after volume expansion.67,68

Patients with congestive acute decompensated cardiac failure have shown improved ventriculo-arterial coupling after diuretic therapy.50 In septic and nonseptic vasoplegia, patients are characterised by ventriculo-arterial uncoupling in relation to high EA and low EV. Despite an increase in blood pressure with norepinephrine administration, only patients who have shown improved EA/EV ratio have also increased their CO, thus improved tissue perfusion.39,47 The potential benefit of esmolol in resuscitated patients with sepsis may be explained by its effect on heart rate and EA, thus ventriculo-arterial coupling.49 Another aspect of the clinical relevance of ventriculo-arterial coupling in ICU is illustrated by the management of blood pressure in patients supported by norepinephrine.69 The use of vasopressor-weaning algorithm based on dynamic EA has decreased the duration of exposure to vasopressor while also improving tissue perfusion.26

Implementation of clinical reasoning around the ventriculo-arterial coupling concept

At present, no study has demonstrated the clinical benefit (improved survival) of haemodynamic algorithms that include ventriculo-arterial coupling. One pilot study performed in patients with sepsis highlighted the potential clinical benefit of early haemodynamic optimisation based on ventriculo-arterial coupling. In this study, patients who were optimised showed improved lactate clearance, with a trend towards decreased mortality. The ideal haemodynamic treatment in patients with acute circulatory failure targets an increase in effectiveness without altering efficiency (i.e. a EA/EV ratio close to 1; Fig. 2).13

The objective of haemodynamic optimisation based on ventriculo-arterial coupling is to measure ventriculo-arterial coupling (i.e. EA/EV ratio), to analyse each component (EA, EV) regarding the clinical context (e.g. cause, treatment and so on) and to obtain a ventriculo-arterial coupling ratio close to 1 by using the right treatment option (Table 3, Fig. 4).17 The knowledge of physiology is the first step to use correct pathways of management of complex ICU scenarios. We can illustrate these points with specific clinical situations, such as acute circulatory failure in the context of cardiogenic shock (Fig. 4) or norepinephrine weaning.

TABLE 3 - Hemodynamic orientation and therapeutic options in ventriculo-arterial uncoupling (i.e. EA/EV ratio >1.36).
EA EV Hemodynamic characteristics Treatment option
High Normal Preload dependence, high blood pressure, tachycardia Volume expansion, vasodilator, beta-blocker
High Low Low inotropic function, high blood pressure, tachycardia, congestion Inodilator, vasodilator, beta-blocker if possible, diuretics
Low Normal or high Low blood pressure Vasopressor
Low Low Low inotropic function, low blood pressure Vasopressor, inotrope

F4
FIGURE 4:
Adjustment of norepinephrine in cardiogenic shock based on VA-coupling. Panel A: before. Panel B: after. EA, arterial elastance; EV, ventricular elastance; LVEF, left ventricular function (%); PEP, preejection period; TSP, total systolic period; VTIAo, integrated time velocity of trans-aortic flow.

Conclusion

Ventriculo-arterial coupling is a concept based on the understanding that the cardiac pump and arterial system ‘work together’ in an integrated manner. The ventriculo-arterial coupling represents a clinical parameter of cardiovascular efficiency associated with cardiovascular performance and clinical outcome, with limited but promising evidence to date. In anaesthesia and intensive care practice, ventriculo-arterial coupling is still considered as ‘novel’ and approached as a research tool. The tools for ventriculo-arterial coupling estimation in routine anaesthesia/intensive care practice, although complex, are now available. The manipulation of ventriculo-arterial (un)coupling may be a part of bedside-available therapeutic strategies aimed at improving outcomes in selected clinical scenarios.

Acknowledgements

Assistance with the article: None declared

Financial support and sponsorship: None declared

Conflicts of interest: None declared

Presentation: None declared

This manuscript was handled by Michelle Chew.

REFERENCES

1. Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail 2019; 21:402–424.
2. O’Rourke MF, Avolio AP, Nichols WW. Yin FCP. Left ventricular-systemic arterial coupling in humans and strategies to improve coupling in disease states. Ventricular/Vascular coupling New York, NY: Springer; 1987.
3. Latus H, Binder W, Kerst G, et al. Right ventricular-pulmonary arterial coupling in patients after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2013; 146:1366–1372.
4. Sagawa K, Suga H, Shoukas AA, et al. End-systolic pressure/volume ratio: Anew index of ventricular contractility. Am J Cardiol 1977; 40:748–753.
5. Sagawa K. The ventricular pressure-volume diagram revisited. Circ Res 1978; 43:677–687.
6. Sunagawa K, Maughan WL, Burkhoff D, et al. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983; 245:H773–H780.
7. Sunagawa K, Sagawa K, Maughan WL. Ventricular interaction with the loading system. Ann Biomed Eng 1984; 12:163–189.
8. Chantler PD. Arterial ventricular uncoupling with age and disease and recoupling with exercise. Exerc Sport Sci Rev 2017; 45:70–79.
9. Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993; 125:1659–1666.
10. Walley KR. Left ventricular function: time-varying elastance and left ventricular aortic coupling. Crit Care 2016; 20:270.
11. Magder S. The meaning of blood pressure. Crit Care 2018; 22:257.
12. Chen CH, Nakayama M, Nevo E, et al. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 1998; 32:1221–1227.
13. Takaoka H, Takeuchi M, Odake M, et al. Assessment of myocardial oxygen consumption (Vo2) and systolic pressure-volume area (PVA) in human hearts. Eur Heart J 1992; 13 (Suppl E):85–90.
14. Chirinos JA. Ventricular-arterial coupling: invasive and noninvasive assessment. Artery Res 2013; 7 1:2–14.
15. Ky B, French B, May Khan A, et al. Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol 2013; 62:1165–1172.
16. Trambaiolo P, Figliuzzi I, Salvati M, et al. Ventriculo-arterial coupling in the intensive cardiac care unit: a noninvasive prognostic parameter. Int J Cardiol 2022; 348:85–89.
17. Andrei S, Nguyen M, Longrois D, et al. Ventriculo-arterial coupling is associated with oxygen consumption and tissue perfusion in acute circulatory failure. Front Cardiovasc Med 2022; 9:842554.
18. Zhou X, Zhang Y, Pan J, et al. Optimizing left ventricular-arterial coupling during the initial resuscitation in septic shock: a pilot prospective randomized study. BMC Anesthesiol 2022; 22:31.
19. Wo N, Rajagopal V, Cheung MMH, et al. Assessment of single beat end-systolic elastance methods for quantifying ventricular contractility. Heart Vessels 2019; 34:716–723.
20. Nguyen M, Berhoud V, Bartamian L, et al. Agreement between different noninvasive methods of ventricular elastance assessment for the monitoring of ventricular-arterial coupling in intensive care. J Clin Monitor Comput 2020; 34:893–901.
21. Chen CH, Fetics B, Nevo E, et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001; 38:2028–2034.
22. Monge Garcia MI, Jian Z, Settels JJ, et al. Reliability of effective arterial elastance using peripheral arterial pressure as surrogate for left ventricular end-systolic pressure. J Clin Monit Comput 2019; 33:803–813.
23. Guinot P-G, Martin A, Berthoud V, et al. Vasopressor-sparing strategies in patients with shock: a scoping review and an evidence-based strategy proposition. J Clin Med 2021; 10:3164.
24. Monge García MI, Jian Z, Hatib F, et al. Dynamic arterial elastance as a ventriculo-arterial coupling index: an experimental animal study. Front Physiol 2020; 11:284.
25. Bar S, Huette P, Abou-Arab O, et al. Dynamic arterial elastance might not be an indicator of ventriculo-arterial coupling. Br J Anaesth 2017; 118:938–946.
26. Guinot P-G, Abou-Arab O, Guilbart M, et al. Monitoring dynamic arterial elastance as a means of decreasing the duration of norepinephrine treatment in vasoplegic syndrome following cardiac surgery: a prospective, randomized trial. Intensive Care Med 2017; 43:643–651.
27. Bar S, Leviel F, Abou Arab O, et al. Dynamic arterial elastance measured by uncalibrated pulse contour analysis predicts arterial-pressure response to a decrease in norepinephrine. Br J Anaesth 2018; 121:534–540.
28. Bar S, Nguyen M, Abou-Arab O, et al. Dynamic arterial elastance is associated with the vascular waterfall in patients treated with norepinephrine: an observational study. Front Physiol 2021; 12:583370.
29. Nguyen M, Abou-Arab O, Bar S, et al. Echocardiographic measure of dynamic arterial elastance predict pressure response during norepinephrine weaning: an observational study. Sci Rep 2021; 11:2853.
30. Wijnberge M, Geerts BF, Hol L, et al. Effect of a machine learning-derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial. JAMA 2020; 323:1052–1060.
31. Pittarello D, Bonato R, Marcassa A, et al. Ventriculo-arterial coupling and mechanical efficiency with remifentanil in patients with coronary artery disease. Acta Anaesthesiol Scand 2004; 48:61–68.
32. Dalla K, Bech-Hanssen O, Ricksten S-E. General anesthesia and positive pressure ventilation suppress left and right ventricular myocardial shortening in patients without myocardial disease: a strain echocardiography study. Cardiovasc Ultrasound 2019; 17:16.
33. Abou Arab O, Fischer MO, Carpentier A, et al. Etomidate-induced hypotension: a pathophysiological approach using arterial elastance. Anaesth Crit Care Pain Med 2019; 38:347–352.
34. Huette P, Abou-Arab O, Longrois D, et al. Fluid expansion improves ventriculo-arterial coupling in preload-dependent patients: a prospective observational study. BMC Anesthesiol 2020; 20:171.
35. Freeman GL, Little WC, O’Rourke RA. Influence of heart rate on left ventricular performance in conscious dogs. Circ Res 1987; 61:455–464.
36. Ohte N, Cheng C-P, Little WC. Tachycardia exacerbates abnormal left ventricular-arterial coupling in heart failure. Heart Vessels 2003; 18:136–141.
37. Martin RS, Norris PR, Kilgo PD, et al. Validation of stroke work and ventricular arterial coupling as markers of cardiovascular performance during resuscitation. J Trauma 2006; 60:930–934. discussion 934–935.
38. Dobson GP. Addressing the global burden of trauma in major surgery. Front Surg 2015; 2:43.
39. Guinot PG, Longrois D, Kamel S, et al. Ventriculo-arterial coupling analysis predicts the hemodynamic response to norepinephrine in hypotensive postoperative patients: a prospective observational study. Crit Care Med 2018; 46:e17–e25.
40. Yan J, Zhou X, Hu B, et al. Prognostic value of left ventricular-arterial coupling in elderly patients with septic shock. J Crit Care 2017; 42:289–293.
41. Nguyen M, Mallat J, Marc J, et al. Arterial load and norepinephrine are associated with the response of the cardiovascular system to fluid expansion. Front Physiol 2021; 12:707832.
42. Guarracino F, Ferro B, Morelli A, et al. Ventriculoarterial decoupling in human septic shock. Crit Care 2014; 18:R80.
43. Andrei S, Popescu BA, Caruso V, Nguyen M, Bouhemad B, Guinot P-G. Role of Electromechanical Dyssynchrony Assessment During Acute Circulatory Failure and Its Relation to Ventriculo-Arterial Coupling. Front Cardiovasc Med 2022; 9:907891 doi: 10.3389/fcvm.2022.907891.
44. Boissier F, Razazi K, Seemann A, et al. Left ventricular systolic dysfunction during septic shock: the role of loading conditions. Intensive Care Med 2017; 43:633–642.
45. Geri G, Vignon P, Aubry A, et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a posthoc analysis. Intensive Care Med 2019; 45:657–667.
46. Li S, Wan X, Laudanski K, et al. Left-sided ventricular-arterial coupling and volume responsiveness in septic shock patients. Shock 2019; 52:577–582.
47. Zhou X, Pan J, Wang Y, et al. Left ventricular-arterial coupling as a predictor of stroke volume response to norepinephrine in septic shock: a prospective cohort study. BMC Anesthesiol 2021; 21:56.
48. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock:. Intensive Care Med 2017; 43:304–377.
49. Morelli A, Singer M, Ranieri VM, et al. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study. Intensive Care Med 2016; 42:1528–1534.
50. Berthelot E, Bihry N, Brault-Melin O, et al. Changes in ventricular-arterial coupling during decongestive therapy in acute heart failure. Eur J Clin Invest 2014; 44:982–988.
51. Fox JM, Maurer MS. Ventriculovascular coupling in systolic and diastolic heart failure. Curr Heart Fail Rep 2005; 2:204–211.
52. Huo Y, Chen H, Kassab GS. Acute tachycardia increases aortic distensibility, but reduces total arterial compliance up to a moderate heart rate. Front Physiol 2018; 9:1634.
53. Kerbaul F, Rondelet B, Motte S, et al. Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2004; 32:1035–1040.
54. Kolh P, Lambermont B, Ghuysen A, et al. Effects of dobutamine on left ventriculoarterial coupling and mechanical efficiency in acutely ischemic pigs. J Cardiovasc Pharmacol 2005; 45:144–152.
55. Freeman GL. Improved cardiac performance secondary to dobutamine: the role of ventricular-vascular coupling. J Am Coll Cardiol 1990; 15:1136–1137.
56. Tavares-Silva M, Alaa M, Leite S, et al. Dose-response head-to-head comparison of inodilators, dobutamine, milrinone, and levosimendan in chronic experimental pulmonary hypertension. J Cardiovasc Pharmacol Therap 2017; 22:485–495.
57. Iacobelli R, Ricci Z, Marinari E, et al. Effects of levosimendan on ventriculo-arterial coupling and cardiac efficiency in paediatric patients with single-ventricle physiology after surgical palliation: retrospective study. Interact Cardiovasc Thorac Surg 2020; 30:623–629.
58. Gustafsson F, Guarracino F, Schwinger RHG. The inodilator levosimendan as a treatment for acute heart failure in various settings. Eur Heart J Suppl 2017; 19:C2–C7.
59. Ishizaka S, Asanoi H, Kameyama T, et al. Ventricular-load optimization by inotropic stimulation in patients with heart failure. Int J Cardiol 1991; 31:51–58.
60. Hsu S, Fang JC, Borlaug BA. Hemodynamics for the heart failure clinician: a state-of-the-art review. J Cardiac Fail 2022; S1071-9164:306–307.
61. Morimont P, Lambermont B, Guiot J, et al. Ejection fraction may not reflect contractility: example in veno-arterial extracorporeal membrane oxygenation for heart failure. ASAIO J 2018; 64:e68–e71.
62. Udesen NLJ, Helgestad OKL, Banke ABS, et al. Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock. Crit Care 2020; 24:95.
63. Andrei S, Tran-Dinh A, Provenchere S, et al. A quantified description of the interactions between the native cardiovascular system and femoro-femoral versus femoro-axillary extracorporeal life support using descending thoracic aorta velocity time integral. Artif Organs 2019; 43:647–655.
64. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004; 44:340–348.
65. Chang MC, Mondy JS, Meredith JW, et al. Redefining cardiovascular performance during resuscitation: ventricular stroke work, power, and the pressure-volume diagram. J Trauma 1998; 45:470–478.
66. Chang MC, Martin RS, Scherer LA, et al. Improving ventricular-arterial coupling during resuscitation from shock: effects on cardiovascular function and systemic perfusion. J Trauma 2002; 53:679–685.
67. Messina A, Romano SM, Ozdemirkan A, et al. Multivariable haemodynamic approach to predict the fluid challenge response: a multicentre cohort study. Eur J Anaesthesiol 2021; 38:22–31.
68. Roger C, Zieleskiewicz L, Demattei C, et al. Time course of fluid responsiveness in sepsis: the fluid challenge revisiting (FCREV) study. Crit Care 2019; 23:179.
69. Andrei S, Nguyen M, Abou-Arab O, et al. Arterial hypotension following norepinephrine decrease in septic shock patients is not related to preload dependence: a prospective, observational cohort study. Front Med (Lausanne) 2022; 9:818386.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society of Anaesthesiology and Intensive Care.